HomeInsightsStock Comparison

Influx Healthtech Ltd vs Lasa Supergenerics Ltd Stock Comparison

Influx Healthtech Ltd vs Lasa Supergenerics Ltd Stock Comparison

Last Updated on: Jul 05, 2025

Key Highlights

  • The Latest Trading Price of Influx Healthtech Ltd is ₹ 131.35 as of 04 Jul 15:30.
  • The P/E Ratio of Influx Healthtech Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Lasa Supergenerics Ltd changed from 31.9 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The Market Cap of Influx Healthtech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Lasa Supergenerics Ltd changed from ₹ 115.51 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The revenue of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Lasa Supergenerics Ltd for the Mar '25 is ₹ 41.53 crore as compare to the Dec '24 revenue of ₹ 41.99 crore. This represent the decline of -1.1%.
  • The ebitda of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Lasa Supergenerics Ltd for the Mar '25 is ₹ -18.11 crore as compare to the Dec '24 ebitda of ₹ 9.18 crore. This represent the decline of -297%.
  • The net profit of Influx Healthtech Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Lasa Supergenerics Ltd changed from ₹ -4.95 crore to ₹ -14.29 crore over 8 quarters. This represents a CAGR of 69.91% .
  • The Dividend Payout of Influx Healthtech Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Lasa Supergenerics Ltd changed from 4.46 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Influx Healthtech Ltd

  • Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
  • Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai. Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.

About Lasa Supergenerics Ltd

  • Lasa Supergenerics Limited was incorporated on March 11, 2016.
  • The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.
  • The Company is a veterinary API manufacturing entity, which was acquired in April, 2012.
  • The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra.
  • It specialises in catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India.

Influx Healthtech Ltd News Hub

News

NSE SME Influx Healthtech makes a strong debut

The scrip was listed at Rs 132.50, a premium of 38.02% compared with the initial public of...

Read more

25 Jun 2025 11:42

Lasa Supergenerics Ltd News Hub

News

Lasa Supergenerics to table results

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 26 May ...

Read more

17 May 2025 13:57

News

Lasa Supergenerics to discuss results

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 13 Febr...

Read more

06 Feb 2025 14:32

News

Lasa Supergenerics to hold EGM

Lasa Supergenerics announced that an Extra Ordinary General Meeting (EGM) of the Company w...

Read more

29 Jan 2025 15:39

News

Lasa Supergenerics to hold board meeting

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 28 Janu...

Read more

23 Jan 2025 11:28

News

Lasa Supergenerics cancels board meeting

Lasa Supergenerics has cancelled the board meeting which was scheduled to be held on 24 Ja...

Read more

23 Jan 2025 10:33

News

Lasa Supergenerics to conduct board meeting

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 24 Janu...

Read more

21 Jan 2025 10:02

SWOT Analysis Of Lasa Supergenerics Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Lasa Supergenerics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Influx Healthtech Ltd and Lasa Supergenerics Ltd

Which company has a larger market capitalization, Influx Healthtech Ltd or Lasa Supergenerics Ltd?

Market cap of Influx Healthtech Ltd is 304 Cr while Market cap of Lasa Supergenerics Ltd is 60 Cr

What are the key factors driving the stock performance of Influx Healthtech Ltd and Lasa Supergenerics Ltd?

The stock performance of Influx Healthtech Ltd and Lasa Supergenerics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Influx Healthtech Ltd and Lasa Supergenerics Ltd?

As of July 5, 2025, the Influx Healthtech Ltd stock price is INR ₹131.35. On the other hand, Lasa Supergenerics Ltd stock price is INR ₹12.02.

How do dividend payouts of Influx Healthtech Ltd and Lasa Supergenerics Ltd compare?

To compare the dividend payouts of Influx Healthtech Ltd and Lasa Supergenerics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions